CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy

Anne Y Lai; Jessica A Sorrentino; Konstantin H Dragnev; Jared M Weiss; Taofeek K Owonikoko; Julie A Rytlewski; Jill Hood; Zhao Yang; Rajesh K Malik; Jay C Strum; Patrick J Roberts

doi:10.1136/jitc-2020-000847

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by topic

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

PDF

Clinical/translational cancer immunotherapy

Original research

CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy

	Abstract	Full	Pdf
Oct 2020	1267	1267	511
Nov 2020	270	270	132
Dec 2020	130	130	58
Jan 2021	204	204	68
Total	1871	1871	769

Main menu

Online download statistics by month:

Online download statistics by month: October 2020 to January 2021

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: October 2020 to January 2021

Read the full text or download the PDF:

Log in using your username and password